Is this Alzheimer's drug a breakthrough for millions? Company unveils mixed results

Is this Alzheimer's drug a breakthrough for millions? Company unveils mixed results

USATODAY.com

Published

Biogen will seek FDA approval for an Alzheimer's drug with mixed results. Can this experimental medication slow the memory-robbing disease?

Full Article